Shukra Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE551C01044
  • NSEID: SHUKRAPHAR
  • BSEID: 524632
INR
84.19
1.97 (2.4%)
BSENSE

Nov 20

BSE+NSE Vol: 6.15 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
44.20
23.52
6.32
39.13
5.88
5.39
13.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
44.20
23.52
6.32
39.13
5.88
5.39
13.27
Raw Material Cost
15.99
1.25
6.69
3.20
10.81
-1.25
5.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
-2.79
-0.75
3.93
-8.80
2.02
-3.83
Employee Cost
4.26
4.39
0.37
2.65
2.19
1.82
1.75
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
5.25
1.53
-0.69
2.22
2.11
1.48
2.44
Total Expenditure (Excl Depreciation)
25.50
4.38
5.62
12.00
6.30
4.07
5.95
Operating Profit (PBDIT) excl Other Income
18.70
19.14
0.70
27.13
-0.42
1.32
7.32
Other Income
0.57
0.54
0.95
0.82
1.71
1.11
1.47
Operating Profit (PBDIT)
19.27
19.68
1.65
27.95
1.29
2.43
8.79
Interest
0.33
0.43
0.26
0.28
0.29
0.27
0.27
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
18.94
19.25
1.39
27.67
1.00
2.16
8.52
Depreciation
1.12
1.08
1.01
0.84
0.81
0.79
0.94
Profit Before Tax
17.83
18.17
0.38
26.83
0.20
1.37
7.57
Tax
5.12
5.21
2.10
6.47
-2.18
0.34
2.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
12.71
12.96
-1.72
20.36
2.38
1.03
5.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
12.71
12.96
-1.72
20.36
2.38
1.03
5.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
12.71
12.96
-1.72
20.36
2.38
1.03
5.39
Equity Capital
44.08
43.79
43.79
43.79
43.79
43.79
43.79
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
0.29
0.3
-0.04
0.46
0.05
0.02
0.12
Diluted Earnings per share
0.29
0.3
-0.04
0.47
0.05
0.02
0.12
Operating Profit Margin (Excl OI)
42.31%
81.38%
11.08%
69.33%
-7.14%
24.49%
55.16%
Gross Profit Margin
42.85%
81.85%
21.99%
70.71%
17.01%
40.07%
64.2%
PAT Margin
28.76%
55.1%
-27.22%
52.03%
40.48%
19.11%
40.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 87.93% vs 273.33% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 6.52% vs 968.79% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 3.77% vs 2,972.46% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -23.26% vs 65.38% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Shukra Pharma. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
44.20
211.64
-167.44
-79.12%
Other Operating Income
0.00
0.00
0.00
Total Operating income
44.20
211.64
-167.44
-79.12%
Raw Material Cost
15.99
24.10
-8.11
-33.65%
Purchase of Finished goods
0.00
58.72
-58.72
-100.00%
(Increase) / Decrease In Stocks
0.00
-10.68
10.68
100.00%
Employee Cost
4.26
44.09
-39.83
-90.34%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
5.25
54.99
-49.74
-90.45%
Total Expenditure (Excl Depreciation)
25.50
171.22
-145.72
-85.11%
Operating Profit (PBDIT) excl Other Income
18.70
40.42
-21.72
-53.74%
Other Income
0.57
4.26
-3.69
-86.62%
Operating Profit (PBDIT)
19.27
44.68
-25.41
-56.87%
Interest
0.33
0.84
-0.51
-60.71%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
18.94
43.84
-24.90
-56.80%
Depreciation
1.12
6.80
-5.68
-83.53%
Profit Before Tax
17.83
37.04
-19.21
-51.86%
Tax
5.12
8.82
-3.70
-41.95%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
12.71
28.22
-15.51
-54.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
12.71
28.22
-15.51
-54.96%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
1.62
-1.62
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
12.71
26.60
-13.89
-52.22%
Equity Capital
44.08
13.23
30.85
233.18%
Face Value
1.00
8.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.29
16.08
-15.79
-98.20%
Diluted Earnings per share
0.29
17.07
-16.78
-98.30%
Operating Profit Margin (Excl OI)
42.31%
19.10%
0.00
23.21%
Gross Profit Margin
42.85%
20.71%
0.00
22.14%
PAT Margin
28.76%
13.33%
0.00
15.43%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 44.20 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 87.93% vs 273.33% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 651.70% vs 5.76% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 16.01 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 6.52% vs 968.79% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 572.69% vs 340.74% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.00 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 3.77% vs 2,972.46% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 5,338.10% vs -162.69% in Sep 2025

Quarterly - Interest
Interest 0.33 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -23.26% vs 65.38% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 13.79% vs 163.64% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 49.77%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025